Presbyopia Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Growing Number of Geriatric Population
   3. Market Restraints
      1. Regulatory Hurdles
      2. High Treatment Costs
   4. Market Opportunities
      1. Increase in the Number of Research and Development Activities
   5. Market Trends
      1. Technological Advancements
      2. Shift Towards Minimally Invasive Procedures
5. MARKET SEGMENTATION
   1. By Diagnosis
      1. Eye Exam
      2. Others
   2. By Symptoms
      1. Eye Strain
      2. Headaches
      3. Fatigue
      4. Blurred Vision
      5. Others
   3. By Treatment
      1. Eyeglasses
      2. Office Progressives
      3. Progressive Multifocals
      4. Bifocals
      5. Trifocals
      6. Prescription Reading Glasses
      7. Contact Lenses
      8. Modified Monovision
      9. Monovision Contact Lenses
      10. Bifocal Contact Lenses
      11. Refractive Surgery
      12. Photorefractive Keratectomy (PRK)
      13. Laser-Assisted Subepithelial Keratectomy (LASEK)
      14. Laser-Assisted in Situ Keratomileusis (LASIK)
      15. Conductive Keratoplasty
      16. Lens Implants
      17. Others
   4. By End-Users
      1. Hospitals
      2. Specialty Clinics
      3. Homecare
      4. Others
   5. By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
      4. Others
   6. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Allergan (Ireland)
      2. Abbott (US)
      3. AstraZeneca (UK)
      4. Alcon Vision LLC (Switzerland)
      5. Bausch Health Companies Inc. (Canada)
      6. F. Hoffmann-La Roche Ltd. (Switzerland)
      7. GlaxoSmithKline plc (UK)
      8. Johnson & Johnson Private Limited (US)
      9. Merck & Co., Inc. (US)
      10. Mylan N.V. (US)
      11. Novartis AG (Switzerland)
      12. Orasis Pharmaceuticals, Inc. (US)
      13. NIDEK CO., LTD. (Japan)
      14. Pfizer Inc. (US)
      15. Sun Pharmaceutical Industries Ltd. (India)
      16. Sanofi (France)
      17. Teva Pharmaceutical Industries Ltd.(Israel)
      18. Ziemer Ophthalmic Systems (Switzerland)
      19. ZEISS International (US)
   2. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Presbyopiamarket?

The global market of Presbyopia is projected to reach USD 16.68Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Presbyopiamarket?

The global Presbyopia market has an estimated annual growth rate of 4.9%.

Q.3. What are the recent trends of Presbyopiamarket?

Technological advancements and shift towards minimally invasive proceduresare some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Presbyopia?

The major companies profiled in this report include Allergan (Ireland), Abbott (US), AstraZeneca (UK), Alcon Vision LLC (Switzerland), Bausch Health Companies Inc. (Canada), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (UK), Johnson & Johnson Private Limited (US), Merck & Co., Inc. (US), Mylan N.V. (US), Novartis AG (Switzerland), Orasis Pharmaceuticals, Inc. (US), NIDEK CO., LTD. (Japan), Pfizer Inc. (US), Sun Pharmaceutical Industries Ltd. (India), Sanofi (France), Teva Pharmaceutical Industries Ltd.(Israel), Ziemer Ophthalmic Systems (Switzerland), ZEISS International (US), among others.

Q.5. Which region is estimated to held highest CAGR inPresbyopiamarket?

North America is estimated to hold biggest share in the market for Presbyopia.